MN-ASI-DATAMYTE
11.12.2015 11:01:06 CET | Business Wire | Press release
ASI DATAMYTE, Inc., the leader in global quality management solutions, announces today a multinational partnership with NEXTSENSE GmbH, the leader in the production of laser-based profile measurement solutions for manufacturers, worldwide. The automotive industry is evolving with more complex designs using a broader variety of materials; which is creating the need for a more comprehensive measurement solutions for ensuring accuracy, inspection thoroughness and operator repeatability. As part of this new relationship, ASI DATAMYTE will now support this market need by offering CALIPRI product line to the automotive industry.
“CALIPRI is one of the fastest-growing, scalable, non-contact measurement solutions in the market,” said Sven Tetzlaff, ASI DATAMYTE GmbH head of product and general manager. “We are confident the combination of CALIPRI and our expertise, technology and client base, creates unmatched value for automotive companies looking to produce higher quality products. We will now have a streamlined solution using one technology supporting the inline and automated measurement throughout the production process.”
“We are committed to continuing our investments and innovation in our state-of-the-art optical sensor technology that will empower the future of ASI DATAMYTE’s clients and distributors,” said Clemens Gasser, chief executive officer, NEXTSENSE GmbH. “We are looking forward to watching our partnership redefine quality measurement and data collection across the globe.”
About ASI DATAMYTE
ASI DATAMYTE Inc. provides integrated software, hardware and services for driving best-in-class quality in manufacturing. Refining its solutions for more than 40 years, ASI DATAMYTE is serving the largest, most prestigious manufacturers with localized solutions on a global basis. ASI DATAMYTE is headquartered in Plymouth, MN, with offices and support centers in more than 40 countries.
About NEXTSENSE
NEXTSENSE GmbH is a global leader in producing and distributing revolutionary solutions for profile measurement and surface inspection, called CALIPRI and SURFILES. All solutions are based on non-contact measurement technology which captures unbiased measurement data removing all outside variables based on differences between operators or environmental conditions. NEXTSENSE devices are used for gap and flush measurement of automotive bodies, wear measurement of railway wheelsets and analyzing the surfaces of rolled steel. The client list ranges from international automobile manufactures (e.g. Volkswagen, Toyota, General Motors) to well-known international enterprises in the railway, steel and technology industry such as SNCF, AcelorMittal and Miele).
View source version on businesswire.com: http://www.businesswire.com/news/home/20151211005140/en/
Contact:
ASI DATAMYTE Inc.
Mary Braunwarth
mary.braunwarth@asidatamyte.com
+1.763.553.0455
info@asidatamyte.com
www.asidatamyte.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
Sutherland Launches FinAI Hub to Industrialize Agentic AI for Banking and Financial Services6.3.2026 14:00:00 CET | Press release
A domain-trained AI agent workforce enables production-scale AI across regulated financial institution operations Today, Sutherland announced the launch of Sutherland FinAI Hub, an enterprise Agentic AI platform built exclusively for Banking and Financial Services. As financial institutions accelerate AI adoption, many initiatives remain confined to pilots, unable to scale across legacy systems and core operations. Sutherland FinAI Hub is designed to help close that gap. FinAI Hub is an innovation ecosystem where Sutherland works with clients to design, prototype, and scale Agentic AI workflows across core operations. At launch, the platform brings together a large and expanding workforce of domain-trained AI agents purpose-built for financial institutions, supporting functions across retail banking, payments, cards, consumer and commercial lending, servicing, back office, risk and compliance functions. These modular agents can operate independently or be orchestrated across end-to-end
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom